Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

Waverley Pharma --WAVE.V (MC $4 M --2 BIG Cancer Drugs close to Approval)

Discussion in 'Canadian Stocks Message Boards' started by Biotechmaster, Jul 27, 2020.

  1. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    281
    Likes Received:
    10
    WAVE.V (MCap 4 Mil) 2x BIG Cancer Drug targeting almost $2 BILLION Market are close to US & Europe approval /its a covid 19 gem too /COMPLETELY unknown stock = This could be a 20 ,30 BAGGER or even more ...


    Waverley Pharma (WAVE.V)

    Market Cap CAD$ 4 million
    Price 0.08


    https://www.waverleypharma.com/generic-product-pipeline.html

    WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications. Currently there is no marketed generic version for this product in the United States, and the brand generates yearly revenue of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe


    WAV-102 is an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. Currently there is no marketed generic for this product and the brand generates yearly revenue of over $800 million USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.



    Waverley Pharma Announces Collaboration withDr. David E. Herbert and the University of Manitoba forthe Development of a Synthetic Library of Chloroquine Analogsto Treat COVID-19
    https://www.waverleypharma.com/uplo...u_of_m_collaboration__25_june_2020__final.pdf
     
  2. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    281
    Likes Received:
    10
    Nice jump but still a BIG GIFT at C$ 7 million valuation


    [​IMG]
     
  3. Kevin Stork

    Kevin Stork New Member

    Joined:
    Jul 28, 2020
    Messages:
    2
    Likes Received:
    0
    Any trading platforms available in Canada with the same pre and post trading hours as in the USA? Or which place is the best in regards to most hours being available pre and post on the NASDAQ, NYSE and ASE?
     
  4. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    281
    Likes Received:
    10
  5. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    281
    Likes Received:
    10
    2 Blockbuster Drugs with US and European approval expected during THIS quarter , market cap of laughable C$ 9 million is more than a PURE GIFT . This UNknown stock could run toward $5 in the coming months

    Share Price: 0.15

    Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States
    https://finance.yahoo.com/news/electric-royalties-closes-acquisition-bissett-114500612.html

    The brands represented by these six generic products, referred to by the Company as WAV-103, WAV-104, WAV-105, WAV-106, WAV-107 and WAV-108, had combined sales of more than $3 billion USD in 2019.
     

Share This Page